Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pamela Cardenas"'
Autor:
Mario Castro, Edward Kerwin, David Miller, Andrew Pedinoff, Lawrence Sher, Pamela Cardenas, Barbara Knorr, David Lawrence, Diego Ossa, Wei Wang, Jorge F Maspero
Publikováno v:
EClinicalMedicine, Vol 35, Iss , Pp 100847- (2021)
Background: These studies assessed the efficacy and safety of fevipiprant, an oral antagonist of the prostaglandin D2 (PGD2) receptor (DP2), compared with placebo when added to standard-of-care (SoC) asthma therapy in patients with uncontrolled asthm
Externí odkaz:
https://doaj.org/article/9701c3aea1214afcb299268838d8fcc0
Autor:
Edward Kerwin, Diego Ossa, Barbara Knorr, Andrew Pedinoff, David Lawrence, David Miller, Jorge Maspero, Lawrence Sher, Wei Wang, Pamela Cardenas, Mario Castro
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 35, Iss, Pp 100847-(2021)
EClinicalMedicine, Vol 35, Iss, Pp 100847-(2021)
Background These studies assessed the efficacy and safety of fevipiprant, an oral antagonist of the prostaglandin D2 (PGD2) receptor (DP2), compared with placebo when added to standard-of-care (SoC) asthma therapy in patients with uncontrolled asthma
Autor:
Kazuomi Kario, Allen Hester, John R. Cockcroft, Jack Zhang, Patrick Brunel, Pamela Cardenas, Dion H. Zappe, Bryan Williams
Publikováno v:
BMJ Open
Introduction Hypertension in elderly people is characterised by elevated systolic blood pressure (SBP) and increased pulse pressure (PP), which indicate large artery ageing and stiffness. LCZ696, a first-in-class angiotensin receptor neprilysin inhib
Publikováno v:
Clinical Cardiology. 16:732-736
This study used 24-h ambulatory blood pressure (BP) monitoring to investigate the effectiveness of a novel low-dose combination of bisoprolol/hydrochlorothiazide in adult patients with mild to moderate essential hypertension. Thirty-six patients with
Autor:
Yuannan Ke, Junren Zhu, Pamela Cardenas, Ruonan Wang, Huashan Hong, Ding-liang Zhu, Ying Zhang
Publikováno v:
Current medical research and opinion. 26(7)
The antihypertensive efficacy of amlodipine/valsartan combination has not been evaluated in Asian patients as previous large-scale studies enrolled very few patients. This multicentre, randomised, double-blind study assessed the efficacy and safety o